glp 1 therapy for diabetes GLP-1 Receptor Agonists as Treatments Type 2 A clinician's perspective 📝 GLP-1

A health technology assessment based on Chinese guidelines: glucagon-like peptide-1 receptor agonist in the treatment of type 2 diabetes complicated with cardiovascular disease

However, the gut microbiome's influence on GLP-1 secretion is complexwhile certain bacterial metabolites like butyrate may support intestinal health, directly stimulating GLP-1 production through probiotics alone has not been validated in large-scale human trials

When an allergic reaction develops due to an exendin based GLP-1 receptor agonist (exenatide, lixisenatide), the usage of a human GLP-1 analogue (liraglutide, dulaglutide, semaglutide) may provide a solution since no cross-reactivity has been reported so far [4, 8]

Its to maintain beliefthat health is still possible